Displaying 1 - 12 of 32
Immune-Mediated and Cholestatic Diseases
4

AdvanzPharma: Shifting Paradigms in PBC Management - EASL Congress 2024

View
Immune-Mediated and Cholestatic Diseases
4

AdvanzPharma: Shifting Paradigms in PBC Management - EASL Congress 2024

View
Immune-Mediated and Cholestatic Diseases
4

AdvanzPharma: Shifting Paradigms in PBC Management - EASL Congress 2024

View
Immune-Mediated and Cholestatic Diseases
4

AdvanzPharma: Shifting Paradigms in PBC Management - EASL Congress 2024

View
Immune-Mediated and Cholestatic Diseases
5

Ipsen: Shining a light on unexplained cholestasis - EASL Congress 2024

View
Immune-Mediated and Cholestatic Diseases
5

Ipsen: Shining a light on unexplained cholestasis - EASL Congress 2024

View
Immune-Mediated and Cholestatic Diseases
5

Ipsen: Shining a light on unexplained cholestasis - EASL Congress 2024

View
Immune-Mediated and Cholestatic Diseases
5

Ipsen: Shining a light on unexplained cholestasis - EASL Congress 2024

View
Immune-Mediated and Cholestatic Diseases
5

Ipsen: Shining a light on unexplained cholestasis - EASL Congress 2024

View
Cirrhosis & Complications
4

Grifols: Long term albumin to manage disease progression: latest evidence and upcoming results - EASL Congress 2024

View
Cirrhosis & Complications
4

Grifols: Long term albumin to manage disease progression: latest evidence and upcoming results - EASL Congress 2024

View
Cirrhosis & Complications
4

Grifols: Long term albumin to manage disease progression: latest evidence and upcoming results - EASL Congress 2024

View